Filing Details

Accession Number:
0000908662-17-000056
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-02 16:06:10
Reporting Period:
2017-02-28
Filing Date:
2017-03-02
Accepted Time:
2017-03-02 16:06:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1528557 Corindus Vascular Robotics Inc. CVRS () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343781 Healthcor Management, L.p. 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1408660 Healthcor Partners Fund Lp 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1409305 Healthcor Associates, Llc 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1409307 Healthcor Group, Llc 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1454849 Healthcor Hybrid Offshore Gp, Llc 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1454850 Healthcor Hybrid Offshore Master Fund, L.p. 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1519456 Healthcor Partners Lp 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1519462 Healthcor Partners Management Lp 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
1519463 Healthcor Partners Management Gp, Llc 152 W. 57Th Street, 43Rd Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-28 7,557,436 $0.66 15,409,537 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,090,941 Indirect See Footnotes
Common Stock 19,981,655 Indirect See Footnotes
Footnotes
  1. HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.
  2. HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein.
  3. HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to each of HCP Fund and HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCP Fund or HCPII Fund except to the extent of any pecuniary interest therein. Mr. Lightcap has separately filed a Form 4.
  4. HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by Hybrid Fund may be deemed to be beneficially owned by HealthCor Hybrid Offshore GP, LLC ("Offshore GP"), its general partner, and by HealthCor Group, LLC ("Group"), the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of shares held by Hybrid Fund except to the extent of any pecuniary interest therein.